Pyramidion Technology Group, Inc (OTC: PYTG), 100% owner of NxGen Brands (“NxGen”) d/b/a: LeafyWell.com (“http://www.LeafyWell.com“) specializing in CBD products, today announced the execution of a binding letter of intent to acquire Renaissance Health Publishing, LLC. (“Renaissance or the “Company”) – A Florida-based company specializing in health and wellness supplements.
Under this agreement, NxGen will acquire 100% of the assets of Renaissance Health Publishing, LLC in cash and stock to complete the acquisition. NxGen will also receive a robust customer base, existing staff and outstanding management team, as well as unique marketing materials and methods designed to advertise the current and existing Renaissance Health Publishing, LLC product lines.
Renaissance is a nationally-known research and development company recognized for its physician-developed, natural health supplements designed to provide health and wellness benefits such as anti-aging, testosterone-boosting, memory-supporting, and libido-boosting effects. Renaissance is perhaps best known for formulating and distributing their own exclusive physician-designed health and wellness supplements manufactured with top-quality ingredients. As a socially-responsible company, they do not perform any animal testing of any kind or at any point during their product research and development. Details on the complete Renaissance product line can be found at RenownHealthProducts.com.
CEO of PYTG, Carlos Hurtado, commented, “We feel that the product lines of Renaissance Health Publishing are of the best on the market and we attribute their incredible success to the quality of the products themselves which have contributed to their long-standing reputation. They have established a numerous customer base and we feel that with this acquisition and the synergy that these products may have with our products at http://www.LeafyWell.com, both our customers and our shareholders will be pleased. It just makes sense – both LeafyWell and Renaissance focus on health and wellness and it is a unique opportunity for us to acquire this company and have the opportunity to increase our customer base – current LeafyWell customers may enjoy the nutraceuticals currently formulated by Renaissance, current Renaissance customers may enjoy the http://www.LeafyWell.com product line, and new customers may enjoy either or both product lines. In our opinion, it is an all-around step in the right direction and we look forward to the effect that this new acquisition would have on our company.”
The Letter of Intent from NxGen Brands to acquire Renaissance Health Publishing, LLC is a binding contract and the proposed acquisition is subject only to finalize the execution of a definitive purchase agreement. To that end, the proposed acquisition would be subject to due diligence and audit approvals.
About Pyramidion Technology Group, Inc:
Pyramidion Technology Group, Inc. (“PYTG” or the “Company”) is best described as a business incubator. The purpose of our business model is to leverage equity, to acquire, merge and or joint venture with early stage companies in emerging sectors, to facilitate growth and cash flow utilizing a diverse distribution method.
Our intention is to develop and acquire fast growing companies in up-trending industries and positioning technology for economic growth. This platform will combine natural relationships, marketing synergies and distribution methods that enable combined companies to provide a wide variety of unique and complete solutions, services and necessities to consumers. We believe our overall business model could effectively create a company of unlimited opportunities for our growing shareholder base.
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/PYTG/filings.
4350 Oakes Rd
Davie, FL 33314